Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Quince Therapeutics, Inc. | 1,000,000 | reported | 23 Jan 2026 | tx 20+8,371,755−980,415 |
| Cidara Therapeutics, Inc. | 80,000 | reported | 16 Mar 2016 | tx 1+80,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Jan 2026 | GRANT_AWARD | Quince Therapeutics, Inc. | 1,000,000 | 0.00 USD | deriv |
| 10 Dec 2025 | GIFT | Quince Therapeutics, Inc. | 739,885 | 0.00 USD | |
| 10 Dec 2025 | GIFT | Quince Therapeutics, Inc. | 739,885 | 0.00 USD | |
| 18 Jun 2025 | GRANT_AWARD | Quince Therapeutics, Inc. | 150,944 | 1.20 USD | |
| 18 Jun 2025 | GRANT_AWARD | Quince Therapeutics, Inc. | 150,944 | 0.13 USD | deriv |
| 28 Jan 2025 | GRANT_AWARD | Quince Therapeutics, Inc. | 1,200,000 | 0.00 USD | deriv |
| 29 Aug 2024 | PURCHASE | Quince Therapeutics, Inc. | 77,500 | 0.69 USD | first after silence |
| 30 Aug 2024 | PURCHASE | Quince Therapeutics, Inc. | 77,000 | 0.70 USD | |
| 01 Feb 2024 | GRANT_AWARD | Quince Therapeutics, Inc. | 1,500,000 | 0.00 USD | deriv |
| 16 Jan 2024 | EXERCISE | Quince Therapeutics, Inc. | 149,999 | 0.94 USD | |
| 16 Jan 2024 | EXERCISE | Quince Therapeutics, Inc. | 90,531 | 0.55 USD | |
| 16 Jan 2024 | EXERCISE | Quince Therapeutics, Inc. | 90,531 | 0.00 USD | deriv |
| 16 Jan 2024 | EXERCISE | Quince Therapeutics, Inc. | 149,999 | 0.00 USD | deriv |
| 10 Aug 2023 | PURCHASE | Quince Therapeutics, Inc. | 88,000 | 1.26 USD | |
| 08 Aug 2023 | PURCHASE | Quince Therapeutics, Inc. | 80,000 | 1.24 USD | |
| 01 Feb 2023 | GRANT_AWARD | Quince Therapeutics, Inc. | 600,000 | 0.00 USD | deriv |
| 19 May 2022 | GRANT_AWARD | Quince Therapeutics, Inc. | 64,589 | — | |
| 23 May 2022 | GRANT_AWARD | Quince Therapeutics, Inc. | 1,979,650 | 0.00 USD | deriv |
| 19 May 2022 | GRANT_AWARD | Quince Therapeutics, Inc. | 206,391 | — | deriv |
| 16 Mar 2016 | GRANT_AWARD | Cidara Therapeutics, Inc. | 80,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 29 Aug 2024.